ID   UBP44_HUMAN             Reviewed;         712 AA.
AC   Q9H0E7; B2RDW3;
DT   10-OCT-2003, integrated into UniProtKB/Swiss-Prot.
DT   13-JUL-2010, sequence version 2.
DT   15-MAR-2017, entry version 139.
DE   RecName: Full=Ubiquitin carboxyl-terminal hydrolase 44;
DE            EC=3.4.19.12;
DE   AltName: Full=Deubiquitinating enzyme 44;
DE   AltName: Full=Ubiquitin thioesterase 44;
DE   AltName: Full=Ubiquitin-specific-processing protease 44;
GN   Name=USP44;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-91.
RC   TISSUE=Testis;
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-91.
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-91.
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   TISSUE SPECIFICITY, AND ENZYME ACTIVITY.
RX   PubMed=14715245; DOI=10.1016/j.bbrc.2003.12.050;
RA   Quesada V., Diaz-Perales A., Gutierrez-Fernandez A., Garabaya C.,
RA   Cal S., Lopez-Otin C.;
RT   "Cloning and enzymatic analysis of 22 novel human ubiquitin-specific
RT   proteases.";
RL   Biochem. Biophys. Res. Commun. 314:54-62(2004).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, PHOSPHORYLATION, DEVELOPMENTAL STAGE,
RP   AND MUTAGENESIS OF CYS-282.
RX   PubMed=17443180; DOI=10.1038/nature05694;
RA   Stegmeier F., Rape M., Draviam V.M., Nalepa G., Sowa M.E., Ang X.L.,
RA   McDonald E.R. III, Li M.Z., Hannon G.J., Sorger P.K., Kirschner M.W.,
RA   Harper J.W., Elledge S.J.;
RT   "Anaphase initiation is regulated by antagonistic ubiquitination and
RT   deubiquitination activities.";
RL   Nature 446:876-881(2007).
RN   [7]
RP   CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, UBIQUITINATION, AND
RP   MUTAGENESIS OF CYS-282.
RX   PubMed=20402667; DOI=10.1042/CBI20090144;
RA   Suresh B., Ramakrishna S., Lee H.J., Choi J.H., Kim J.Y., Ahn W.S.,
RA   Baek K.H.;
RT   "K48- and K63-linked polyubiquitination of deubiquitinating enzyme
RT   USP44.";
RL   Cell Biol. Int. 34:799-808(2010).
RN   [8]
RP   INDUCTION.
RX   PubMed=20505756; DOI=10.1371/journal.pone.0010709;
RA   Jung M., Peterson H., Chavez L., Kahlem P., Lehrach H., Vilo J.,
RA   Adjaye J.;
RT   "A data integration approach to mapping OCT4 gene regulatory networks
RT   operative in embryonic stem cells and embryonal carcinoma cells.";
RL   PLoS ONE 5:E10709-E10709(2010).
RN   [9]
RP   TISSUE SPECIFICITY.
RX   PubMed=21853124; DOI=10.1371/journal.pone.0023389;
RA   Zhang Y., van Deursen J., Galardy P.J.;
RT   "Overexpression of ubiquitin specific protease 44 (USP44) induces
RT   chromosomal instability and is frequently observed in human T-cell
RT   leukemia.";
RL   PLoS ONE 6:E23389-E23389(2011).
RN   [10]
RP   FUNCTION.
RX   PubMed=22681888; DOI=10.1016/j.molcel.2012.05.023;
RA   Fuchs G., Shema E., Vesterman R., Kotler E., Wolchinsky Z., Wilder S.,
RA   Golomb L., Pribluda A., Zhang F., Haj-Yahya M., Feldmesser E.,
RA   Brik A., Yu X., Hanna J., Aberdam D., Domany E., Oren M.;
RT   "RNF20 and USP44 regulate stem cell differentiation by modulating H2B
RT   monoubiquitylation.";
RL   Mol. Cell 46:662-673(2012).
RN   [11]
RP   PHOSPHORYLATION AT SER-169; SER-239; THR-269 AND SER-401, AND
RP   DEPHOSPHORYLATION.
RX   PubMed=22692537; DOI=10.1038/ncomms1886;
RA   Visconti R., Palazzo L., Della Monica R., Grieco D.;
RT   "Fcp1-dependent dephosphorylation is required for M-phase-promoting
RT   factor inactivation at mitosis exit.";
RL   Nat. Commun. 3:894-894(2012).
CC   -!- FUNCTION: Deubiquitinase that plays a key regulatory role in the
CC       spindle assembly checkpoint or mitotic checkpoint by preventing
CC       premature anaphase onset. Acts by specifically mediating
CC       deubiquitination of CDC20, a negative regulator of the anaphase
CC       promoting complex/cyclosome (APC/C). Deubiquitination of CDC20
CC       leads to stabilize the MAD2L1-CDC20-APC/C ternary complex (also
CC       named mitotic checkpoint complex), thereby preventing premature
CC       activation of the APC/C. Promotes association of MAD2L1 with CDC20
CC       and reinforces the spindle assembly checkpoint. Acts as a negative
CC       regulator of histone H2B (H2BK120ub1) ubiquitination.
CC       {ECO:0000269|PubMed:17443180, ECO:0000269|PubMed:22681888}.
CC   -!- CATALYTIC ACTIVITY: Thiol-dependent hydrolysis of ester,
CC       thioester, amide, peptide and isopeptide bonds formed by the C-
CC       terminal Gly of ubiquitin (a 76-residue protein attached to
CC       proteins as an intracellular targeting signal).
CC       {ECO:0000269|PubMed:14715245, ECO:0000269|PubMed:17443180,
CC       ECO:0000269|PubMed:20402667}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20402667}.
CC       Note=Peaks in interphase, with relatively low levels maintained
CC       throughout mitosis. {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expressed in testis. Expressed at high levels
CC       in T-cell acute lymphoblastic leukemia.
CC       {ECO:0000269|PubMed:14715245, ECO:0000269|PubMed:21853124}.
CC   -!- DEVELOPMENTAL STAGE: Elevated in mitosis; levels increase in
CC       mitotic cells and rapidly decrease once cells have completed
CC       chromosome attachment and exit from mitosis.
CC       {ECO:0000269|PubMed:17443180}.
CC   -!- INDUCTION: Transcriptionally regulated by POU5F1/OCT4 in embryonic
CC       stem cells and embryonal carcinoma cells.
CC       {ECO:0000269|PubMed:20505756}.
CC   -!- PTM: Dephosphorylated by CTDP1.
CC   -!- PTM: Ubiquitinated; undergoes both 'Lys-48'- and 'Lys-63'-linked
CC       polyubiquitination and is degraded by the proteasome.
CC       {ECO:0000269|PubMed:20402667}.
CC   -!- SIMILARITY: Belongs to the peptidase C19 family. USP44 subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL136825; CAB66759.1; -; mRNA.
DR   EMBL; AK315697; BAG38060.1; -; mRNA.
DR   EMBL; AC018475; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC030704; AAH30704.1; -; mRNA.
DR   CCDS; CCDS9053.1; -.
DR   RefSeq; NP_001035862.1; NM_001042403.2.
DR   RefSeq; NP_001265322.1; NM_001278393.1.
DR   RefSeq; NP_001334865.1; NM_001347936.1.
DR   RefSeq; NP_001334866.1; NM_001347937.1.
DR   RefSeq; NP_115523.2; NM_032147.4.
DR   RefSeq; XP_016875499.1; XM_017020010.1.
DR   UniGene; Hs.646421; -.
DR   UniGene; Hs.710121; -.
DR   ProteinModelPortal; Q9H0E7; -.
DR   BioGrid; 123890; 11.
DR   IntAct; Q9H0E7; 11.
DR   MINT; MINT-4719317; -.
DR   STRING; 9606.ENSP00000258499; -.
DR   MEROPS; C19.057; -.
DR   iPTMnet; Q9H0E7; -.
DR   PhosphoSitePlus; Q9H0E7; -.
DR   DMDM; 300669621; -.
DR   EPD; Q9H0E7; -.
DR   PaxDb; Q9H0E7; -.
DR   PeptideAtlas; Q9H0E7; -.
DR   PRIDE; Q9H0E7; -.
DR   DNASU; 84101; -.
DR   Ensembl; ENST00000258499; ENSP00000258499; ENSG00000136014.
DR   Ensembl; ENST00000393091; ENSP00000376806; ENSG00000136014.
DR   Ensembl; ENST00000537435; ENSP00000442629; ENSG00000136014.
DR   GeneID; 84101; -.
DR   KEGG; hsa:84101; -.
DR   UCSC; uc001teg.5; human.
DR   CTD; 84101; -.
DR   DisGeNET; 84101; -.
DR   GeneCards; USP44; -.
DR   H-InvDB; HIX0010895; -.
DR   HGNC; HGNC:20064; USP44.
DR   HPA; HPA026543; -.
DR   MIM; 610993; gene.
DR   neXtProt; NX_Q9H0E7; -.
DR   OpenTargets; ENSG00000136014; -.
DR   PharmGKB; PA134931457; -.
DR   eggNOG; KOG1867; Eukaryota.
DR   eggNOG; ENOG410XQQ0; LUCA.
DR   GeneTree; ENSGT00870000136393; -.
DR   HOGENOM; HOG000015084; -.
DR   HOVERGEN; HBG018027; -.
DR   InParanoid; Q9H0E7; -.
DR   KO; K11834; -.
DR   OMA; AIKSQNY; -.
DR   OrthoDB; EOG091G02YX; -.
DR   PhylomeDB; Q9H0E7; -.
DR   TreeFam; TF315281; -.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   ChiTaRS; USP44; human.
DR   GeneWiki; USP44; -.
DR   GenomeRNAi; 84101; -.
DR   PRO; PR:Q9H0E7; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000136014; -.
DR   CleanEx; HS_USP44; -.
DR   ExpressionAtlas; Q9H0E7; baseline and differential.
DR   Genevisible; Q9H0E7; HS.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0004843; F:thiol-dependent ubiquitin-specific protease activity; IDA:UniProtKB.
DR   GO; GO:0036459; F:thiol-dependent ubiquitinyl hydrolase activity; TAS:Reactome.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0007067; P:mitotic nuclear division; IEA:UniProtKB-KW.
DR   GO; GO:1904667; P:negative regulation of ubiquitin protein ligase activity; IMP:UniProtKB.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; ISS:UniProtKB.
DR   GO; GO:0016579; P:protein deubiquitination; IDA:UniProtKB.
DR   GO; GO:0090266; P:regulation of mitotic cell cycle spindle assembly checkpoint; ISS:UniProtKB.
DR   GO; GO:0090231; P:regulation of spindle checkpoint; IMP:UniProtKB.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR001394; Peptidase_C19_UCH.
DR   InterPro; IPR018200; USP_CS.
DR   InterPro; IPR028889; USP_dom.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR001607; Znf_UBP.
DR   Pfam; PF00443; UCH; 1.
DR   Pfam; PF02148; zf-UBP; 1.
DR   SMART; SM00290; ZnF_UBP; 1.
DR   PROSITE; PS00972; USP_1; 1.
DR   PROSITE; PS00973; USP_2; 1.
DR   PROSITE; PS50235; USP_3; 1.
DR   PROSITE; PS50271; ZF_UBP; 1.
PE   1: Evidence at protein level;
KW   Cell cycle; Cell division; Complete proteome; Hydrolase;
KW   Metal-binding; Mitosis; Nucleus; Phosphoprotein; Polymorphism;
KW   Protease; Reference proteome; Thiol protease; Ubl conjugation;
KW   Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN         1    712       Ubiquitin carboxyl-terminal hydrolase 44.
FT                                /FTId=PRO_0000080673.
FT   DOMAIN      273    678       USP.
FT   ZN_FING      27     88       UBP-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00502}.
FT   ACT_SITE    282    282       Nucleophile.
FT   ACT_SITE    636    636       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10092, ECO:0000255|PROSITE-
FT                                ProRule:PRU10093}.
FT   MOD_RES     169    169       Phosphoserine.
FT                                {ECO:0000305|PubMed:22692537}.
FT   MOD_RES     239    239       Phosphoserine.
FT                                {ECO:0000305|PubMed:22692537}.
FT   MOD_RES     269    269       Phosphothreonine.
FT                                {ECO:0000305|PubMed:22692537}.
FT   MOD_RES     401    401       Phosphoserine.
FT                                {ECO:0000305|PubMed:22692537}.
FT   VARIANT      91     91       T -> A (in dbSNP:rs3812813).
FT                                {ECO:0000269|PubMed:11230166,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_017125.
FT   VARIANT     316    316       E -> Q (in dbSNP:rs7305024).
FT                                /FTId=VAR_057043.
FT   VARIANT     348    348       R -> G (in dbSNP:rs7135642).
FT                                /FTId=VAR_057044.
FT   MUTAGEN     282    282       C->S,A: Abolishes deubiquitinase
FT                                activity. {ECO:0000269|PubMed:17443180,
FT                                ECO:0000269|PubMed:20402667}.
SQ   SEQUENCE   712 AA;  81185 MW;  A8211DFAD78EE731 CRC64;
     MLAMDTCKHV GQLQLAQDHS SLNPQKWHCV DCNTTESIWA CLSCSHVACG RYIEEHALKH
     FQESSHPVAL EVNEMYVFCY LCDDYVLNDN TTGDLKLLRR TLSAIKSQNY HCTTRSGRFL
     RSMGTGDDSY FLHDGAQSLL QSEDQLYTAL WHRRRILMGK IFRTWFEQSP IGRKKQEEPF
     QEKIVVKREV KKRRQELEYQ VKAELESMPP RKSLRLQGLA QSTIIEIVSV QVPAQTPASP
     AKDKVLSTSE NEISQKVSDS SVKRRPIVTP GVTGLRNLGN TCYMNSVLQV LSHLLIFRQC
     FLKLDLNQWL AMTASEKTRS CKHPPVTDTV VYQMNECQEK DTGFVCSRQS SLSSGLSGGA
     SKGRKMELIQ PKEPTSQYIS LCHELHTLFQ VMWSGKWALV SPFAMLHSVW RLIPAFRGYA
     QQDAQEFLCE LLDKIQRELE TTGTSLPALI PTSQRKLIKQ VLNVVNNIFH GQLLSQVTCL
     ACDNKSNTIE PFWDLSLEFP ERYQCSGKDI ASQPCLVTEM LAKFTETEAL EGKIYVCDQC
     NSKRRRFSSK PVVLTEAQKQ LMICHLPQVL RLHLKRFRWS GRNNREKIGV HVGFEEILNM
     EPYCCRETLK SLRPECFIYD LSAVVMHHGK GFGSGHYTAY CYNSEGGFWV HCNDSKLSMC
     TMDEVCKAQA YILFYTQRVT ENGHSKLLPP ELLLGSQHPN EDADTSSNEI LS
//
